169 related articles for article (PubMed ID: 34999838)
1. Sexual Dimorphism in Small-intestinal Neuroendocrine Tumors: Lower Prevalence of Mesenteric Disease in Premenopausal Women.
Blažević A; Iyer AM; van Velthuysen MF; Hofland J; Oudijk L; de Herder WW; Hofland LJ; Feelders RA
J Clin Endocrinol Metab; 2022 Apr; 107(5):e1969-e1975. PubMed ID: 34999838
[TBL] [Abstract][Full Text] [Related]
2. Small intestinal neuroendocrine tumours and fibrosis: an entangled conundrum.
Blažević A; Hofland J; Hofland LJ; Feelders RA; de Herder WW
Endocr Relat Cancer; 2018 Mar; 25(3):R115-R130. PubMed ID: 29233841
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of small intestinal neuroendocrine tumors and mesenteric fibrosis.
Blažević A; Iyer AM; van Velthuysen MF; Hofland J; Franssen GJH; Feelders RA; Zajec M; Luider TM; de Herder WW; Hofland LJ
Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36951556
[TBL] [Abstract][Full Text] [Related]
4. Differential Protein Expression in Small Intestinal Neuroendocrine Tumors and Liver Metastases.
Kim MK; Ye F; Wang D; Cui M; Ward SC; Warner RR; Roayaie S; Shafir M; Schwartz M; Zhang D; Itzkowitz S
Pancreas; 2016 Apr; 45(4):528-32. PubMed ID: 26474427
[TBL] [Abstract][Full Text] [Related]
5. Decrease of 5-hydroxymethylcytosine and TET1 with nuclear exclusion of TET2 in small intestinal neuroendocrine tumors.
Barazeghi E; Prabhawa S; Norlén O; Hellman P; Stålberg P; Westin G
BMC Cancer; 2018 Jul; 18(1):764. PubMed ID: 30045709
[TBL] [Abstract][Full Text] [Related]
6. Clinical signs of fibrosis in small intestinal neuroendocrine tumours.
Daskalakis K; Karakatsanis A; Stålberg P; Norlén O; Hellman P
Br J Surg; 2017 Jan; 104(1):69-75. PubMed ID: 27861745
[TBL] [Abstract][Full Text] [Related]
7. Mesenteric fibrosis in patients with small intestinal neuroendocrine tumors is associated with enrichment of alpha-smooth muscle actin-positive fibrosis and COMP-expressing stromal cells.
Graf SD; Keber CU; Hattesohl A; Teply-Szymanski J; Hattesohl S; Guder M; Gercke N; Di Fazio P; Slater EP; Jesinghaus M; Denkert C; Bartsch DK; Lehman B
J Neuroendocrinol; 2024 Feb; 36(2):e13364. PubMed ID: 38246597
[TBL] [Abstract][Full Text] [Related]
8. Aberrant tryptophan metabolism in stromal cells is associated with mesenteric fibrosis in small intestinal neuroendocrine tumors.
Blažević A; Iyer AM; van Velthuysen MF; Hofland J; van Koestveld PM; Franssen GJH; Feelders RA; Zajec M; Luider TM; de Herder WW; Hofland LJ
Endocr Connect; 2022 Apr; 11(4):. PubMed ID: 35275095
[TBL] [Abstract][Full Text] [Related]
9. Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors: an in vivo and in vitro study.
Fotouhi O; Adel Fahmideh M; Kjellman M; Sulaiman L; Höög A; Zedenius J; Hashemi J; Larsson C
Epigenetics; 2014 Jul; 9(7):987-97. PubMed ID: 24762809
[TBL] [Abstract][Full Text] [Related]
10. Mesenteric fibrosis and palliative surgery in small intestinal neuroendocrine tumours.
Blažević A; Zandee WT; Franssen GJH; Hofland J; van Velthuysen MF; Hofland LJ; Feelders RA; de Herder WW
Endocr Relat Cancer; 2018 Mar; 25(3):245-254. PubMed ID: 29255095
[TBL] [Abstract][Full Text] [Related]
11. A plausible role for actin gamma smooth muscle 2 (ACTG2) in small intestinal neuroendocrine tumorigenesis.
Edfeldt K; Hellman P; Westin G; Stalberg P
BMC Endocr Disord; 2016 Apr; 16():19. PubMed ID: 27107594
[TBL] [Abstract][Full Text] [Related]
12. TCEB3C a putative tumor suppressor gene of small intestinal neuroendocrine tumors.
Edfeldt K; Ahmad T; Åkerström G; Janson ET; Hellman P; Stålberg P; Björklund P; Westin G
Endocr Relat Cancer; 2014 Apr; 21(2):275-84. PubMed ID: 24351681
[TBL] [Abstract][Full Text] [Related]
13. Independent somatic evolution underlies clustered neuroendocrine tumors in the human small intestine.
Elias E; Ardalan A; Lindberg M; Reinsbach SE; Muth A; Nilsson O; Arvidsson Y; Larsson E
Nat Commun; 2021 Nov; 12(1):6367. PubMed ID: 34737276
[TBL] [Abstract][Full Text] [Related]
14. Somatic mutation of CDKN1B in small intestine neuroendocrine tumors.
Francis JM; Kiezun A; Ramos AH; Serra S; Pedamallu CS; Qian ZR; Banck MS; Kanwar R; Kulkarni AA; Karpathakis A; Manzo V; Contractor T; Philips J; Nickerson E; Pho N; Hooshmand SM; Brais LK; Lawrence MS; Pugh T; McKenna A; Sivachenko A; Cibulskis K; Carter SL; Ojesina AI; Freeman S; Jones RT; Voet D; Saksena G; Auclair D; Onofrio R; Shefler E; Sougnez C; Grimsby J; Green L; Lennon N; Meyer T; Caplin M; Chung DC; Beutler AS; Ogino S; Thirlwell C; Shivdasani R; Asa SL; Harris CR; Getz G; Kulke M; Meyerson M
Nat Genet; 2013 Dec; 45(12):1483-6. PubMed ID: 24185511
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Clinical Prognostic Factors and Further Delineation of the Effect of Mesenteric Fibrosis on Survival in Advanced Midgut Neuroendocrine Tumours.
Laskaratos FM; Walker M; Wilkins D; Tuck A; Ramakrishnan S; Phillips E; Gertner J; Megapanou M; Papantoniou D; Shah R; Banks J; Vlachou E; Garcia-Hernandez J; Woodbridge L; Papadopoulou A; Grant L; Theocharidou E; Watkins J; Luong TV; Mandair D; Caplin M; Toumpanakis C
Neuroendocrinology; 2018; 107(3):292-304. PubMed ID: 30153671
[TBL] [Abstract][Full Text] [Related]
16. Melatonin Immunoreactivity in Malignant Small Intestinal Neuroendocrine Tumours.
Söderquist F; Janson ET; Rasmusson AJ; Ali A; Stridsberg M; Cunningham JL
PLoS One; 2016; 11(10):e0164354. PubMed ID: 27736994
[TBL] [Abstract][Full Text] [Related]
17. Proteomics identifies neddylation as a potential therapy target in small intestinal neuroendocrine tumors.
Fotouhi O; Kjellin H; Juhlin CC; Pan Y; Vesterlund M; Ghaderi M; Yousef A; Andersson-Sand H; Kharaziha P; Caramuta S; Kjellman M; Zedenius J; Larsson C; Orre LM
Oncogene; 2019 Oct; 38(43):6881-6897. PubMed ID: 31406256
[TBL] [Abstract][Full Text] [Related]
18. The ETS oncogene family transcription factor FEV identifies serotonin-producing cells in normal and neoplastic small intestine.
Wang YC; Zuraek MB; Kosaka Y; Ota Y; German MS; Deneris ES; Bergsland EK; Donner DB; Warren RS; Nakakura EK
Endocr Relat Cancer; 2010 Mar; 17(1):283-91. PubMed ID: 20048018
[TBL] [Abstract][Full Text] [Related]
19. Mesenteric tumour deposits arising from small-intestine neuroendocrine tumours are frequently associated with fibrosis and IgG4-expressing plasma cells.
Roberts J; Gonzalez RS; Revetta F; Shi C
Histopathology; 2018 Nov; 73(5):795-800. PubMed ID: 29943407
[TBL] [Abstract][Full Text] [Related]
20. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Cigrovski Berković M; Čačev T; Catela Ivković T; Marout J; Ulamec M; Zjačić-Rotkvić V; Kapitanović S
Mol Cell Endocrinol; 2016 Apr; 425():61-8. PubMed ID: 26805636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
